Braud Sandrine, Le Bonniec Bernard F, Bon Cassian, Wisner Anne
Unité des Venins, Institut Pasteur, 25 rue du Dr. Roux, 75015 Paris, France.
Biochemistry. 2002 Jul 2;41(26):8478-84. doi: 10.1021/bi016069g.
The plasminogen activator isolated from the venom of the snake Trimeresurus stejnegeri (TSV-PA) triggers plasmin production, along with tissue-type plasminogen activators (t-PA) and urokinase (u-PA). The half-life of TSV-PA in plasma is remarkable. We unveil in this paper two of the molecular mechanisms allowing TSV-PA to escape inhibition by plasma serpins. The first involves a phenylalanine at position 193 (chymotrypsinogen numbering system). Phe(193) distinguishes TSV-PA from nearly all trypsin-like proteinases, having glycine at this position. A mutant of TSV-PA (F193G), in which Phe(193) had been replaced by a glycine, was inactivated by plasminogen activator inhibitor 1 (PAI-1) and alpha(2)-antiplasmin 100-fold more rapidly than the wild-type enzyme. The second mechanism originates from the 37-loop of TSV-PA. Swapping the 37-loop of TSV-PA for either that of t-PA or that of u-PA also increased dramatically the rate of inactivation by PAI-1. Loop swapping and F193G mutations were additive, resulting in a rate of inactivation by PAI-1 that was 4 orders of magnitude higher than for the wild-type enzyme. The potential role of Phe(193) and of the 37-loop in the immunity of TSV-PA toward alpha(1)-antitrypsin and antithrombin is also discussed.
从竹叶青蛇毒液中分离出的纤溶酶原激活剂(TSV-PA)可触发纤溶酶的产生,与组织型纤溶酶原激活剂(t-PA)和尿激酶(u-PA)一样。TSV-PA在血浆中的半衰期很长。我们在本文中揭示了TSV-PA逃避血浆丝氨酸蛋白酶抑制剂抑制的两种分子机制。第一种机制涉及193位的苯丙氨酸(胰凝乳蛋白酶原编号系统)。Phe(193)使TSV-PA与几乎所有胰蛋白酶样蛋白酶区分开来,这些蛋白酶在该位置为甘氨酸。TSV-PA的一个突变体(F193G),其中Phe(193)被甘氨酸取代,被纤溶酶原激活剂抑制剂1(PAI-1)和α2-抗纤溶酶灭活的速度比野生型酶快100倍。第二种机制源于TSV-PA的37环。将TSV-PA的37环换成t-PA或u-PA的37环也显著增加了PAI-1的灭活速度。环交换和F193G突变具有累加效应,导致PAI-1的灭活速度比野生型酶高4个数量级。还讨论了Phe(193)和37环在TSV-PA对α1-抗胰蛋白酶和抗凝血酶免疫中的潜在作用。